January 17, 2019January 17, 2019
High-dose Vitamin B12 May Improve ALS Prognosis if Started Early, Study Suggests
News
Treatment with ultra-high-dose methylcobalamin, the physiologically active form of vitamin B12, may improve the prognosis of patients with amyotrophic ... Read more
January 16, 2019January 16, 2019
First, We Must Answer the Key Question: What Is ALS?
Columns, Notes From the ALS Front - a Column by Rick Jobus
It’s complicated. That trite, two-word sentence has become, in the age of social media, the go-to characterization of any ... Read more
January 16, 2019January 16, 2019
Muscular Dystrophy Association Gives AcuraStem $300K Boost to Develop ALS Therapy
News
A $300,000 grant from the Muscular Dystrophy Association (MDA) will back AcuraStem’s preclinical development of an amyotrophic lateral sclerosis (ALS) ... Read more
January 15, 2019January 11, 2019
Riding Out the Lag Time
Columns, Living Well with ALS - a column by Dagmar Munn
Yup, it’s that time of year again — lag time! We’re in that weird space in time that’s just ... Read more
January 15, 2019January 15, 2019
Early and Consistent Weight Loss Linked to Poorer Outcomes in ALS, Study Suggests
News
The rate of weight loss from onset to diagnosis can be a significant indicator of poorer outcomes among amyotrophic ... Read more
January 14, 2019January 14, 2019
Human-derived Antibody Against SOD1 Aggregates Improves ALS Symptoms in Mouse Model, Study Shows
News
A human-derived antibody that specifically binds to abnormal superoxide dismutase 1 (SOD1) improved the symptoms and delayed disease progression in ... Read more
January 11, 2019January 11, 2019
Disease Progression Has Significant Effect on Quality of Life of ALS Patients, Study Says
News
In addition to symptoms of depression, disease progression is one of the strongest influences on health-related quality of life ... Read more
January 10, 2019January 10, 2019
CuATSM Therapy May Slow ALS Progression, Improving Cognition and Respiration in Patients, Phase 1 Trial Shows
News
CuATSM, one of the lead investigational therapies of Collaborative Medicinal Development (CMD), may slow disease progression and improve the ... Read more
January 9, 2019January 10, 2019
I’m Back to Wish Readers a Happy New Year
Columns, Notes From the ALS Front - a Column by Rick Jobus
“Reports of my demise have been greatly exaggerated.” —Mark Twain, in a letter to The New York Sun I ... Read more
January 9, 2019January 9, 2019
EnClear, Developer of Device to Slow ALS, Spins Out of QurAlis
News
EnClear Therapies, a biotech company developing a device to halt the progression of neurological diseases including amyotrophic lateral sclerosis ... Read more
January 8, 2019January 4, 2019
The Power of One Resolution
Columns, Living Well with ALS - a column by Dagmar Munn
The new year is just beginning, and my email inbox is already overflowing with suggestions about the importance of ... Read more
January 8, 2019January 8, 2019
Healthcare AI Company and Neurological Center Collaborating on New Tool to Improve ALS Management
News
CloudMedx plans to develop a computer analysis algorithm that will track the clinical progression of patients with amyotrophic lateral ... Read more

January 17, 2019January 17, 2019

High-dose Vitamin B12 May Improve ALS Prognosis if Started Early, Study Suggests

News

Treatment with ultra-high-dose methylcobalamin, the physiologically active form of vitamin B12, may improve the prognosis of patients with amyotrophic lateral sclerosis (ALS) who receive it a year or less ... Read more

January 16, 2019January 16, 2019

First, We Must Answer the Key Question: What Is ALS?

Columns, Notes From the ALS Front - a Column by Rick Jobus

It’s complicated. That trite, two-word sentence has become, in the age of social media, the go-to characterization of any couple whose pairing defies analysis. In the best case, after ... Read more

January 16, 2019January 16, 2019

Muscular Dystrophy Association Gives AcuraStem $300K Boost to Develop ALS Therapy

News

A $300,000 grant from the Muscular Dystrophy Association (MDA) will back AcuraStem’s preclinical development of an amyotrophic lateral sclerosis (ALS) patient-derived stem cell therapy that has the potential to treat a ... Read more

January 15, 2019January 11, 2019

Riding Out the Lag Time

Columns, Living Well with ALS - a column by Dagmar Munn

Yup, it’s that time of year again — lag time! We’re in that weird space in time that’s just after all the holiday hoopla and before the “next big ... Read more

January 15, 2019January 15, 2019

Early and Consistent Weight Loss Linked to Poorer Outcomes in ALS, Study Suggests

News

The rate of weight loss from onset to diagnosis can be a significant indicator of poorer outcomes among amyotrophic lateral sclerosis (ALS) patients, a study reports. The study, “Early ... Read more

January 14, 2019January 14, 2019

Human-derived Antibody Against SOD1 Aggregates Improves ALS Symptoms in Mouse Model, Study Shows

News

A human-derived antibody that specifically binds to abnormal superoxide dismutase 1 (SOD1) improved the symptoms and delayed disease progression in a mouse model for amyotrophic lateral sclerosis (ALS), a study ... Read more

January 11, 2019January 11, 2019

Disease Progression Has Significant Effect on Quality of Life of ALS Patients, Study Says

News

In addition to symptoms of depression, disease progression is one of the strongest influences on health-related quality of life in amyotrophic lateral sclerosis (ALS) patients, a study reports. According to the study, ... Read more

January 10, 2019January 10, 2019

CuATSM Therapy May Slow ALS Progression, Improving Cognition and Respiration in Patients, Phase 1 Trial Shows

News

CuATSM, one of the lead investigational therapies of Collaborative Medicinal Development (CMD), may slow disease progression and improve the respiratory and cognitive function of patients with amyotrophic lateral sclerosis ... Read more

January 9, 2019January 10, 2019

I’m Back to Wish Readers a Happy New Year

Columns, Notes From the ALS Front - a Column by Rick Jobus

“Reports of my demise have been greatly exaggerated.” —Mark Twain, in a letter to The New York Sun I spent the better part of November under the weather. I ... Read more

January 9, 2019January 9, 2019

EnClear, Developer of Device to Slow ALS, Spins Out of QurAlis

News

EnClear Therapies, a biotech company developing a device to halt the progression of neurological diseases including amyotrophic lateral sclerosis (ALS), announced it has spun out from QurAlis, one of its ... Read more

January 8, 2019January 4, 2019

The Power of One Resolution

Columns, Living Well with ALS - a column by Dagmar Munn

The new year is just beginning, and my email inbox is already overflowing with suggestions about the importance of setting goals and resolutions. But for many living with ALS, ... Read more

January 8, 2019January 8, 2019

Healthcare AI Company and Neurological Center Collaborating on New Tool to Improve ALS Management

News

CloudMedx plans to develop a computer analysis algorithm that will track the clinical progression of patients with amyotrophic lateral sclerosis (ALS) to predict treatment outcomes. This tool will be ... Read more